The Dutch National Renal Denervation Registry

• Register: ClinicalTrials.gov
• Last refreshed on: 3 August 2015
• Main ID: NCT02482103
• Date of registration: 11/06/2015
• Prospective Registration: No
• Primary sponsor: UMC Utrecht
• Public title: The Dutch National Renal Denervation Registry NL_RDN_REG
• Scientific title: Safety, Success Rate and Long Term Consequences of Renal Denervation in Patients With Therapy Resistant Hypertension. The Dutch National Renal Denervation Registry
• Date of first enrolment: April 2013
• Target sample size: 1000
• Recruitment status: Recruiting
• URL: https://clinicaltrials.gov/show/NCT02482103
• Study type: Observational [Patient Registry]
• Study design: Observational Model: Cohort, Time Perspective: Prospective
• Phase: N/A

Countries of recruitment

Netherlands

Contacts

• Name: Michiel Bots, MD, PhD

• Name: Michiel L. Bots, Prof.

• Name: Michiel L. Bots, MD, PhD
• Affiliation: Julius Center for Health Sciences and Primary Care

Key inclusion & exclusion criteria

Inclusion Criteria:

- treated with renal denervation. The decision to perform the procedure was made by the
treating physician in the participating hospitals

Exclusion Criteria:

- below age of 18 years



Age minimum: 18 Years
Age maximum: 95 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Hypertension

Intervention(s)

Procedure: Renal denervation

Primary Outcome(s)

Change in blood pressure [Time Frame: 6 months]

Secondary Outcome(s)

safety aspects: long term kidney function [Time Frame: 5 years]

safety aspects (change in renal function) [Time Frame: 5 years]

longterm consequences: kidney function [Time Frame: 5 years]

longterm consequences: mortality [Time Frame: 5 years]

longterm consequences: CVD events [Time Frame: 5 years]

safety aspects: procedures complication [Time Frame: 1 year]

Secondary ID(s)

NL-RDN_REG

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Dutch Kidney Foundation